Joshi told CNBC-TV18, "For me, Lupin is a definite hold. Among the domestic pharma companies, Lupin is a stock that I continue to like. In case of results, from whatever I can see are positive surprise because on the EBITDA and revenue front that is definitely a beat. Revenue performance is quite good and on the PAT level they have done extremely well. So, to my mind there is no reason to sell."
She further said, "The kind of numbers that they have shown and the traction that they have shown is likely to continue. So, I would keep the stock with a target of about Rs 760."
Anda sedang membaca artikel tentang
Hold Lupin, target of Rs 760: Sharmila Joshi
Dengan url
http://harmonisem.blogspot.com/2013/05/hold-lupin-target-of-rs-760-sharmila.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Hold Lupin, target of Rs 760: Sharmila Joshi
namun jangan lupa untuk meletakkan link
Hold Lupin, target of Rs 760: Sharmila Joshi
sebagai sumbernya
0 komentar:
Posting Komentar